These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


193 related items for PubMed ID: 8458526

  • 1. Insulin sensitivity, insulin secretion and glucose effectiveness in diabetic and non-diabetic cirrhotic patients.
    Kruszynska YT, Harry DS, Bergman RN, McIntyre N.
    Diabetologia; 1993 Feb; 36(2):121-8. PubMed ID: 8458526
    [Abstract] [Full Text] [Related]

  • 2. Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis.
    Kruszynska YT, Home PD, McIntyre N.
    Hepatology; 1991 Jul; 14(1):103-11. PubMed ID: 2066059
    [Abstract] [Full Text] [Related]

  • 3. Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients.
    Kruszynska YT, Goulas S, Wollen N, McIntyre N.
    J Hepatol; 1998 Feb; 28(2):280-91. PubMed ID: 9514541
    [Abstract] [Full Text] [Related]

  • 4. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis.
    Petrides AS, Vogt C, Schulze-Berge D, Matthews D, Strohmeyer G.
    Hepatology; 1994 Mar; 19(3):616-27. PubMed ID: 8119686
    [Abstract] [Full Text] [Related]

  • 5. Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.
    Amoah AG, Owusu SK, Schuster DP, Osei K.
    S Afr Med J; 2002 May; 92(5):377-84. PubMed ID: 12108171
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Insulin sensitivity, insulin secretion, and glucose effectiveness in subjects with impaired glucose tolerance: a minimal model analysis.
    Taniguchi A, Nakai Y, Fukushima M, Imura H, Kawamura H, Nagata I, Florant GL, Tokuyama K.
    Metabolism; 1994 Jun; 43(6):714-8. PubMed ID: 8201959
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance.
    Lanng S, Thorsteinsson B, Røder ME, Orskov C, Holst JJ, Nerup J, Koch C.
    Acta Endocrinol (Copenh); 1993 Mar; 128(3):207-14. PubMed ID: 8480468
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests.
    van Haeften TW, Dubbeldam S, Zonderland ML, Erkelens DW.
    Diabetes Care; 1998 Feb; 21(2):278-82. PubMed ID: 9539996
    [Abstract] [Full Text] [Related]

  • 12. Hyperinsulinaemia and insulin resistance of cirrhosis: the importance of insulin hypersecretion.
    Proietto J, Dudley FJ, Aitken P, Alford FP.
    Clin Endocrinol (Oxf); 1984 Dec; 21(6):657-65. PubMed ID: 6391746
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Insulin response to glucose and tolbutamide in "essential" versus "pancreatic" mild glucose intolerance.
    Vague P, Ramahandridona G, Gerolami A.
    Diabetes; 1974 Nov; 23(11):896-901. PubMed ID: 4430416
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients.
    Henriksen JE, Alford F, Ward GM, Beck-Nielsen H.
    Diabetologia; 1997 Dec; 40(12):1439-48. PubMed ID: 9447952
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
    Sakai T, Ohneda A, Nihei J, Kobayashi T.
    Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
    [Abstract] [Full Text] [Related]

  • 19. Insulin secretion and plasma levels of glucose-dependent insulinotropic peptide and glucagon-like peptide 1 [7-36 amide] after oral glucose in cirrhosis.
    Kruszynska YT, Ghatei MA, Bloom SR, McIntyre N.
    Hepatology; 1995 Apr; 21(4):933-41. PubMed ID: 7705803
    [Abstract] [Full Text] [Related]

  • 20. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
    Henriksen JE, Levin K, Thye-Rønn P, Alford F, Hother-Nielsen O, Holst JJ, Beck-Nielsen H.
    Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.